



Polymeric Nanoparticles in Dermocosmetic
Nanopartículas Poliméricas en Dermocosmética
Bahamonde-Norambuena, D.*; Molina-Pereira, A.*; Mario Cantin**;
Muñoz, M.***,****; Katherine Zepeda***** & Cristian Vilos******,*******
BAHAMONDE-NORAMBUENA, D.; MOLINA-PEREIRA, A.; CANTIN, M.; MUÑOZ, M.; ZEPEDA, K. & VILOS, C. Polymeric
nanoparticles in dermocosmetic. Int. J. Morphol., 33(4):1563-1568, 2015.
SUMMARY: Recent advances in the fields of biomaterials and nanotechnology have allowed the development of advanced
nanoparticles for biomedical applications. Despite a vast number of nanostructures such as liposomes, solid–lipid nanocapsules, polymeric
and hybrid lipid–polymer nanoparticles have been studied as carriers for drug delivery for different pathologies with remarkable promising
results; the use of polymeric nanoparticles in dermocosmetic still has not been widely explored. The evolution of cosmetic into the care skin
and dermatology represents novel technological challenges. Also, the increasing knowledge about normal skin physiology and advances in
nanotechnology provide an attractive environment for the creation of innovative dermocosmetic formulations. In this work, we discuss the
state of the art of polymeric nanoparticles formulated for dermocosmetics, its mechanisms of action, and diffusion into the skin.
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INTRODUCTION
The applications of nanotechnology in the human
health demand the use of biomaterials with biodegradability
and biocompatibility properties. The attribute of
biodegradability is due when the environmental conditions
induce the degradation of biomaterials by biocatalysis
processes (e.g. fungi, bacteria, enzymes), chemical or radi-
cal processes (e.g. hydrolysis, oxidation, UV radiation) (Guo
et al., 2012; Thouand, 2014). The biocompatibility is the
ability of a material to perform an appropriate host response
in a particular application, that include be non-toxic, non-
cancerogenic, non-mutagenic, non-allergenic, free from
contaminants (e.g., additives, solvents, and synthesis
residues), bioresorbability, does not induce adverse
immunological response, and its degradation products be
also biocompatible (Kim et al., 2010; Vilos & Velasquez,
2012).
Biodegradable and biocompatible synthetic polymers
have been intensely investigated in the formulation of drug
delivery systems because they provide a strong platform to
prepare stable, and homogenous nanoparticles loaded with
drugs that present predictable fashion release (Choi et al.,
2014; Vilos et al., 2012, 2013, 2014, 2015; Cantín et al.,
2013; Vilos, 2014).
Also, these polymers can be combined with other
copolymers, and functionalized with targeting molecules
improving the pharmacological effectiveness of the drugs
(Fredman et al., 2015). On this context, the number and
possibilities of multifunctional nanostructures able to create
with those polymers is unprecedented (Kamaly et al., 2012;
Xu et al., 2015). Another property of polymeric nanoparticles
is its highly talented to penetrate biological barriers such as
endothelial, tissues, and skin (Barua & Mitragotri, 2014). 
Skin represents a symbol of beauty, and the use of
cosmetics to enhance personal appearance has been described
since ancient civilizations. Currently, the facial aesthetic is
the main reason for dermatological consultation (Freitag &
Cestari, 2007). The modern cosmetics have taken a new role
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in dermatology by ensuring care, and skin health, along with
improving the appearance (Dreno et al., 2014). In this
context, dermocosmetics is an emerging field that is
incorporating innovative approaches based on polymeric
nanoparticles and promises to introduce new paradigms in
the cosmetics industry (Morganti, 2010). In this work, we
discuss the state of the art of polymeric nanoparticles
formulated for dermocosmetics purposes, its mechanisms
of action and diffusion in the skin, and the future
perspectives.
Polymeric nanostructures. Current advances in
pharmaceutical technology provide support to generate
nanostructures with different inner morphology able to load
bioactive compounds with diverse chemical nature. Figure
1 describes the most common types of polymeric
nanoparticles: nanospheres (matrix system) and
nanocapsules (reservoir system). Nanospheres usually
incorporate the bioactive molecule between the polymer
networks, while nanocapsules typically load water dissolving
the drug in the core contained in a polymeric shell (Guterres
et al., 2007; Vilos & Velasquez).
Skin. The skin has a complex morphology. The skin and its
appendages (hair follicles, sweat glands, sebaceous glands,
nails, and mammary glands) establish the integumentary
system. Histologically, skin has two main layers-the epider-
mis and the dermis-with a subcutaneous fascia called the
hypodermis, which lies deep in the dermis. The epidermis is
formed of four to five layers of cells made mostly out of
keratinocytes, along with three other different and less
abundant cells; the dermis underlies the epidermis, and the
hypodermis is a looser connective tissue that is located
beneath the dermis (it blends to the dermis with an unclear
boundary) (Arda et al., 2014).
The skin represents between 12—15% of body
weight and covers a surface area of about 1.2—1.3 m2. The
thickness of the skin is less than 2 mm and comprises of
three layers: the epidermis, dermis, and hypodermis. The
outer skin layer (epidermis) poses a rate-limiting barrier for
diffusion and consists of keratin-filled dead cells entirely
surrounded by ceramides, triglycerides, cholesterols and free
fatty acids. The mechanical support of the skin is localized
in the dermis and is characterized by elastin and collagen
fibers. This layer also is highly vascularized and permeable
to solutes, containing the sebaceous glands, hair follicles,
and sweat glands (Bouwstra & Honeywell-Nguyen, 2002).
The major challenge in topical drug delivery is across
the skin (stratum corneum) because it is an efficient physical
barrier. The absorption of any kind of material there can be
considered two general pathways: through the stratum
corneum and the underlying layers or along the skin
appendages. Generally, the stratum corneum is assumed to
be the main barrier for absorption, through the corneocytes
or along the intercellular spaces along the lipid matrix, the
latter most suited for penetration, offering channel-like
structures providing higher diffusivity although the pathway
is much longer (Schneider et al., 2009). The stratum corneum
can be considered to be a lipoidic compartment whereas the
underlying living tissue is a more aqueous environment.
Hence lipophilic molecules can distribute more easily in the
stratum corneum and penetration is facilitated, and the
absorbent needs to fit into the intercellular space and need
to move along the lipid phase or the aqueous phase,
respectively, restricting the space available and therefore the
size of penetrating species influences the absorption
behavior. Diffusion into the living tissue, however, is in fa-
vor of polar molecules and objects restricting the invasion
of too lipophilic compounds. As a consequence only
substances with partition coefficients between 1 and 3 are
well suited for skin absorption (Schneider et al.).
Dermocosmetic based polymeric nanoparticles
provide broad opportunities for preventing aging and skin
care, as well as for dermatological affections such as
psoriasis, acne, eczema, skin mycosis, and inflammations
(Papakostas et al., 2011).
Skin diffusion of nanoparticles. The penetration of
polymeric nanoparticles into the skin as a carrier of bioactive
compounds has been rarely investigated. Studies carried out
using confocal laser scanning microscopy (CLSM) to
analyze the distribution of fluorescent polystyrene
nanoparticles with a diameter of 20 and 200 nm in porcine
skin demonstrated the preferential accumulation of the
particles in the follicular openings, and particularly the
particle size of 20 nm. Moreover, the quantity nanoparticles
accumulated in the skin was in a time–dependent manner
(Alvarez-Roman et al., 2004a). In another study of cross-
sectional images obtained by CLSM from porcine ear, skin
treated with Nile Red–loaded poly(e-caprolactone) (PLC)
nanoparticles (250 nm), Nile Red solution in propylene
glycol, and Nile red saturated solution in propylene glycol
showed a deeper fluorescence distribution in the skin of Nile
Red from nanoparticles samples reaching a thickness of 60
mm (Alvarez-Roman et al., 2004b).
A comparative study between hollow polymeric
nanocapsules particle size 178 nm and zeta potential -11 mV,
with lipid–core polymeric nanocapsules particle size 180
nm and zeta potential -9 mV showed a deeper penetration of
hollow polymeric nanocapsules (dermis vs. outermost layers
of the skin respectively) suggesting that the mechanical
flexibility of nanoparticles is a critical factor for the skin
BAHAMONDE-NORAMBUENA, D.; MOLINA-PEREIRA, A.; CANTIN, M.; MUÑOZ, M.; ZEPEDA, K. & VILOS, C. Polymeric nanoparticles in dermocosmetic.
Int. J. Morphol., 33(4):1563-1568, 2015.
1565
penetration (de Brum et al., 2015). Figure 2, shows a scheme
of the penetration of polymeric nanoparticles in the skin.
The transepidermal drug delivery also was
investigated with polylactic acid (PLA) nanoparticles loaded
with Nile Red (228 nm) and coumarin-6 (365 nm) in human
skin explants obtained from healthy volunteers undergoing
plastic surgery. The obtained results demonstrate in both
cases that ~50% of the particles penetrated deep in the vellus
hair follicles, suggesting that when the nanoparticles are in
contact with the skin surface, they suffer destabilization and
significant release of incorporated dye (Rancan et al., 2009).
Those results later were confirmed using the same PLA
nanoparticles loaded with the hydrophilic fluorochrome 4-
Di- 2-Asp, and with the lipophilic fluorochrome Bodipy 630/
650. In this study, the authors also conclude that diffusion
kinetics depended on the lipophilicity of the dye (bioactive
compound), and the stability and release properties of the
particles could be modulated incorporating excipients with
different degree of lipophilicity (Rancan et al., 2012).
Dermocosmetic Applications. The main advantages using
polymeric nanoparticles in drug delivery and
dermocosmetics involve the creation of strong platforms that
allow to reduce the cytotoxicity, overcome several biological
barriers and provide a sustained and targeted release of
bioactive molecules. The use of sunscreen in the population
is an essential self–care carefulness since the adverse effects
of ultraviolet radiation (UVR) on the skin. The use of
titanium dioxide, and zinc oxide nanoparticles in sunscreen
current is highly accepted, however, the risk of generation
of free radicals, and subsequent side effects to promote the
study of novel biomaterials for sunscreen. A recent study
developed a set of sunscreen creams based on morin–loaded
PLGA nanoparticles, which combined with titanium and zinc
dioxide nanoparticles exhibited high deposit and diffusion
in the skin with excellent SPF (Sun Protection factor) values
and effective antioxidant effect. This investigation based in
PLGA nanoparticles loaded with morin, a natural polyphenol
with photoprotection and antioxidants properties, promise a
high impact of polymeric nanoparticles in sunscreen creams
development (Shetty et al., 2015).
Vitamin K1 is an active antioxidant used in
dermatology with recognized anti-age effects. Studies
performed with Vitamin K1–loaded polymeric nanocapsules
prepared from PLC (diameter of 211±2 nm, and zeta potential
of –14.9±0.6 mV) showed significant skin permeation into
of dermis. This place is where Vitamin K1 exhibits its effects
in the treatment of dark circles, telangiectasia and bruising
of the skin (da Silva et al., 2013). These biomaterials and
nanotechnology could be applied in wound healing with
treatment based on Ulmo honey (E. cordifolia) supplemented
with ascorbic acid (Schencke et al., 2013).
Skin inflammation is a typical manifestation of
Fig. 1. Scheme of polymeric nanostructures (A) nanospheres
(matrix system) and (B) nanocapsules (reservoir system) typically
used in dermocosmetics.
Fig. 2. Schematic description of the layers of the skin (epidermis, dermis, and
hypodermis), and the penetration of nanoparticles into its diverse structures.
several disorders of the skin arisen by
different factors such as skin exposure to
the sun, irritant chemicals, heat or insect
bites that affect the health, and aesthetic of
the skin. In this context, nanoparticles
synthesized from ethyl cellulose and
betamethasone in a range of size between
50 to 1000 nm was studied in an experi-
mental dithranol-induced dermatitis
inflammation model in mice ears. The
analysis of skin penetration of particles was
size–dependent manner and were smaller
nanoparticles (100 and 50 nm) diffused
better into the hair follicle. Also, those
particles were highly accumulated in the
sebaceous glands. The anti-inflammatory
effect was found in the treatment with both
particle sizes BetaNP1000 (1000 nm), and
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BetaNP100 (100 nm), however, the therapeutic response was
much higher with the BetaNP100, due to its high diffusion
within the stratum corneum (Abdel-Mottaleb et al., 2012).
The use of hair follicle as selective targeting tool for
dermatotherapy represents also a remarkable opportunity for
the developments of novel strategies for dermocosmetics,
and immunotherapy (Mittal et al., 2013; Vogt et al., 2005).
The diffusion of polymeric nanoparticles into the hair follicle
has been well described, as well as, its storage into the follicle
even for ten days (Lademann et al., 2007). Recent strategies
of chitosan nanoparticles encapsulating the drug minoxidil
(MXS-NP) for the treatment of alopecia have showed
promising results. MXS-NP increased in a two-fold the
concentration of drug into the hair follicles after six hours
of treatment in comparison to the control solution (Matos et
al., 2015).
Transcutaneous immunization is another concept that
refers to the needle-free application of vaccines across the
skin. The literature has described that the skin holds an
abundance of professional antigen-presenting cells such as
dendritic cells, and Langerhans cells. Therefore, the use of
polymeric nanoparticles could provide novel strategies for
transfollicular delivery of antigens. A recent study using
PLGA and chitosan-coated PLGA nanoparticles loaded with
ovalbumin showed a high follicular uptake of nanoparticles.
Also, the study of activation of dendritic cells showed a
positive proliferation of antigen-specific CD8+ and CD4+
T cells supporting the maintenance of the integrity of the
antigen during the process of synthesis of nanoparticles and
the efficacy of cell stimulation. In this context, the
transcutaneous immunization represents a potent concept for
patients with an impaired immune system or the elderly
(Mittal et al.).
Concluding remarks
The use of polymeric nanoparticles in cosmetic
dermatology offers a range of new opportunities for both
maintenance of the health, and physiological properties of
the skin, as well as creating better products cosmetics (e.g.
incorporating metal nanoparticles copper or gold).
Furthermore, The nanoparticles allow to improve the
physicochemical properties of the classic cream emulsions
and to enhance the penetration of the bioactive compounds
until deep layers of the skin. The next generation of particles
as nanocarriers could offer an arsenal of cargo molecules
that allow keeping the hydration of the skin, elasticity,
cellular matrix equilibrium, and other functions related with
the beauty. Hair follicular delivery based polymeric
nanoparticles represents a powerful non-invasive route of
administration for skin maintenance and systemic stimulation
for the development of novel vaccines.
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 RESUMEN: Los recientes avances en el campo de los biomateriales y la nanotecnología han permitido el desarrollo de nanopartículas
avanzadas para aplicaciones biomédicas. A pesar de que un gran número de nanoestructuras tales como liposomas, nanocápsulas lípido-
sólidas, nanopartículas poliméricas y lípido-polímero híbridas han sido estudiadas como vehículos para la administración de fármacos en
diferentes patologías con notables resultados prometedores, el uso de nanopartículas poliméricas en dermocosmética todavía no ha sido
ampliamente explorado. La evolución de la cosmética en el cuidado de la piel y la dermatología nos enfrentan a nuevos retos tecnológi-
cos. Además, el aumento de los conocimientos sobre la fisiología de la piel normal y los avances en la nanotecnología proporcionan un
entorno atractivo para la creación de formulaciones dermocosméticas innovadoras. En este trabajo se discute el estado del arte de las
nanopartículas poliméricas desarrolladas para dermocosmética, sus mecanismos de acción y la difusión en la piel.
PALABRAS CLAVE: Nanotecnología; Nanopartículas poliméricas; Morfología de la piel; Cosméticos; Dermocosmética.
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